High ITGA7 surface expression has been negatively correlated with glioblastoma patient survival, and targeting ITGA7 by RNAi has been shown to lead to a significant reduction of tumor cell invasion in vitro [6]. The gene discussed is ITGA7; the disease is glioblastoma.